Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Orphanet Journal of Rare Diseases
Published in: Orphanet Journal of Rare Diseases 1/2016

Open Access 01-12-2016 | Research

Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C

Authors: L. H. Koens, A. Kuiper, M. A. Coenen, J. W. J. Elting, J. J. de Vries, M. Engelen, J. H. T. M. Koelman, F. J. van Spronsen, J. M. Spikman, T. J. de Koning, M. A. J. Tijssen

Published in: Orphanet Journal of Rare Diseases | Issue 1/2016

Login to get access

Abstract

Background

Niemann-Pick type C (NP-C) is a rare autosomal recessive progressive neurodegenerative disorder caused by mutations in the NP-C 1 or 2 gene. Besides visceral symptoms, presentation in adolescent and adult onset variants is often with neurological symptoms. The most frequently reported presenting symptoms of NP-C in adulthood are psychiatric symptoms (38 %), cognitive decline (23 %) and ataxia (20 %). Myoclonus can be present, but its value in early diagnosis and the evolving clinical phenotype in NP-C is unclear. In this paper we present eight Dutch cases of NP-C of whom five with myoclonus.

Methods

Eight patients with genetically confirmed NP-C were recruited from two Dutch University Medical Centers. A structured interview and neuropsychological tests (for working and verbal memory, attention and emotion recognition) were performed. Movement disorders were assessed using a standardized video protocol. Quality of life was evaluated by questionnaires (Rand-36, SIP-68, HAQ). In four of the five patients with myoclonic jerks simultaneous EEG with EMG was performed.

Results

A movement disorder was the initial neurological symptom in six patients: three with myoclonus and three with ataxia. Two others presented with psychosis. Four experienced cognitive deficits early in the course of the disease. Patients showed cognitive deficits in all investigated domains. Five patients showed myoclonic jerks, including negative myoclonus. In all registered patients EEG-EMG coherence analysis and/or back-averaging proved a cortical origin of myoclonus. Patients with more severe movement disorders experienced significantly more physical disabilities.

Conclusions

Presenting neurological symptoms of NP-C include movement disorders, psychosis and cognitive deficits. At current neurological examination movement disorders were seen in all patients. The incidence of myoclonus in our cohort was considerably higher (63 %) than in previous publications and it was the presenting symptom in 38 %. A cortical origin of myoclonus was demonstrated. Our data suggest that myoclonus may be overlooked in patients with NP-C. All patients scored significantly lower on physical domains of HRQoL. Symptomatic treatment of movement disorders may improve physical functioning and subsequently HRQoL.
Literature
1.
2.
Imrie J, Heptinstall L, Knight S, Strong K. Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database. BMC Neurol. 2015;15(1):257. 015-0511-1.CrossRefPubMedPubMedCentral
3.
Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis. 2013;8:12. 1172-8-12.CrossRefPubMedPubMedCentral
4.
Anheim M, Lagha-Boukbiza O, Fleury-Lesaunier MC, Valenti-Hirsch MP, Hirsch E, Gervais-Bernard H, et al. Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-Pick C disease. J Neurol. 2014;261(1):174–9.CrossRefPubMed
5.
Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, et al. The adult form of Niemann-Pick disease type C. Brain. 2007;130(Pt 1):120–33.PubMed
6.
Mengel E, Klunemann HH, Lourenco CM, Hendriksz CJ, Sedel F, Walterfang M, et al. Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis. 2013;8:166. 1172-8-166.CrossRefPubMedPubMedCentral
7.
Patterson MC, Mengel E, Vanier MT, Schwierin B, Muller A, Cornelisse P, et al. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study. Orphanet J Rare Dis. 2015;10:65. 015-0284-z.CrossRefPubMedPubMedCentral
8.
Wijburg FA, Sedel F, Pineda M, Hendriksz CJ, Fahey M, Walterfang M, et al. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology. 2012;78(20):1560–7.CrossRefPubMed
9.
Canafoglia L, Bugiani M, Uziel G, Dalla Bernardina B, Ciano C, Scaioli V, et al. Rhythmic cortical myoclonus in Niemann-Pick disease type C. Mov Disord. 2006;21(9):1453–6.CrossRefPubMed
10.
Van Egmond ME, Elting JW, Kuiper A, Zutt R, Heineman KR, Brouwer OF, et al. Myoclonus in childhood-onset neurogenetic disorders: The importance of early identification and treatment. Eur J Paediatr Neurol. 2015;19(6):726–9.
11.
Stampfer M, Theiss S, Amraoui Y, Jiang X, Keller S, Ory DS, et al. Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators. Orphanet J Rare Dis. 2013;8:35. 1172-8-35.CrossRefPubMedPubMedCentral
12.
Klunemann HH, Santosh PJ, Sedel F. Treatable metabolic psychoses that go undetected: what Niemann-Pick type C can teach us. Int J Psychiatry Clin Pract. 2012;16(3):162–9.CrossRefPubMed
13.
Klarner B, Klunemann HH, Lurding R, Aslanidis C, Rupprecht R. Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations. J Inherit Metab Dis. 2007;30(1):60–7.CrossRefPubMed
14.
Walterfang M, van de Warrenburg BP. Cognitive impairment in “Other” movement disorders: hidden defects and valuable clues. Mov Disord. 2014;29(5):694–703.CrossRefPubMed
15.
Busner J, Targum SD. The Clinical Global Impressions Scale: Applying a Research Tool in Clinical Practice. Psychiatry (Edgmont). 2007;4(7):28–37.
16.
Young A, Perrett D, Calder A, Sprengelmeyer R, Ekman P. Facial Expression of Emotion: Stimuli and Tests (FEEST). Bury St. Edmunds, England: Thames Valley Test Company; 2002.
17.
Wechsler D. Wechsler Adult Intelligence Scale IV (WAIS-IV). Amsterdam: Pearson; 2008.
18.
Schlichting L. Peabody Picture Vocabulary Test-Third Edition NL (PPVT-III-NL). Amsterdam: Pearson; 1997.
19.
Schmand B, Lindeboom J, van Harskamp F. Nederlandse Leestest voor Volwassenen (NLV) [Dutch version of the National Adult Reading Test]. Lisse: Swets & Zeitlinger; 1992.
20.
Wechsler D. Wechsler Adult Intelligence Scale III (WAIS-III) [Intelligence test for adults]. Lisse: Swets & Zeitlinger; 1997.
21.
Deelman B, Brouwer W, van Zomeren A, Saan R. In: Jennekens-Schinkel A, Diamant J, et al., editors. Functiestoornissen na trauma capitis. Neuropsychologie in Nederland. Deventer: Van Loghum Slaterus; 1980.
22.
Reitan R, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation. Tucson: Neuropsychology Press; 1985.
23.
Krishnan E, Sokka T, Hakkinen A, Hubert H, Hannonen P. Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population. Arthritis Rheum. 2004;50(3):953–60.CrossRefPubMed
24.
Zee KI van der, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36, een handleiding. Groningen: Rijksuniversiteit Groningen, Noordelijk Centrum voor Gezondheidsvraagstukken; 2012.
25.
Dijk JM, Tijssen MA. Management of patients with myoclonus: available therapies and the need for an evidence-based approach. Lancet Neurol. 2010;9(10):1028–36.CrossRefPubMed
26.
Levy A, Chen R. Myoclonus: Pathophysiology and Treatment Options. Curr Treat Options Neurol. 2016;18(5):21. 016-0404-7.CrossRefPubMed
27.
Ganos C, Kassavetis P, Erro R, Edwards MJ, Rothwell J, Bhatia KP. The role of the cerebellum in the pathogenesis of cortical myoclonus. Mov Disord. 2014;29(4):437–43.CrossRefPubMed
28.
Tijssen MA, Thom M, Ellison DW, Wilkins P, Barnes D, Thompson PD, et al. Cortical myoclonus and cerebellar pathology. Neurology. 2000;54(6):1350–6.CrossRefPubMed
29.
Bhatia KP, Brown P, Gregory R, Lennox GG, Manji H, Thompson PD, et al. Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain. 1995;118(Pt 5):1087–93.CrossRefPubMed
30.
Tang Y, Li H, Liu JP. Niemann-Pick Disease Type C: from molecule to clinic. Clin Exp Pharmacol Physiol. 2010;37(1):132–40.CrossRefPubMed
31.
Lopez ME, Scott MP. Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type C. Dis Model Mech. 2013;6(5):1089–100.CrossRefPubMedPubMedCentral
32.
Van Egmond ME, Verschuuren-Bemelmans CC, Nibbeling EA, Elting JW, Sival DA, Brouwer OF, et al. Ramsay Hunt syndrome: clinical characterization of progressive myoclonus ataxia caused by GOSR2 mutation. Mov Disord. 2014;29(1):139–43.
Metadata
Title
Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C
Authors
L. H. Koens
A. Kuiper
M. A. Coenen
J. W. J. Elting
J. J. de Vries
M. Engelen
J. H. T. M. Koelman
F. J. van Spronsen
J. M. Spikman
T. J. de Koning
M. A. J. Tijssen
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2016
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-016-0502-3

Other articles of this Issue 1/2016

Orphanet Journal of Rare Diseases 1/2016 Go to the issue

Research

Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995–2012

Research

Establishment of reference values of α-tocopherol in plasma, red blood cells and adipose tissue in healthy children to improve the management of chylomicron retention disease, a rare genetic hypocholesterolemia

Erratum

Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment

Research

Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net)

Erratum

Erratum to: CMTX1 patients’ cells present genomic instability corrected by CamKII inhibitors

Research

Current models of care for disorders of sex development – results from an International survey of specialist centres